Slingshot members are tracking this event:
Intercept Pharmaceuticals (ICPT) plans to commence Phase 3 obeticholic acid (OCA) cirrhosis trial in the second half of 2017
Slingshot Insights Explained
Feb 12, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Obeticholic Acid, Cirrhosis, Phase 3